News

Both companies have signed a multi-year collaboration to jointly identify targets for the treatment of Alzheimer’s disease with the Research Institute of Molecular Pathology in Vienna.

Broad Institute receives $100M gift from Stanley Medical Research Institute to study the genomics and chemical biology of schizophrenia, bipolar disorder.

Biosite will have access to Compugen’s diagnostic and immunoassay biomarkers under a renewed and expanded partnership and licensing agreement.

The US Patent 7,185, 969 describes microplates used in high-throughput screening that have low electrical resistance.

To meet the growing Customer demand, Syrris expands its US sales and customer service team with the opening of an office in La Jolla, CA, to provide support for its modular flow chemistry and synthesis products.

Carl Zeiss has acquired the equipment business of the US Company Clarient to strengthen its clinical cancer diagnostics and cancer research.

VentiRx acquires exclusive worldwide rights to toll-like receptor program from Array to develop candidates in oncology and allergy.

Medical College of Georgia researchers will use a test to measure a tumor's aggressiveness in more than 10,000 women to identify the patients who need chemotherapy.

Opaldia has launched the programme incorporating genetic testing, screening and information services to help patients make informed decisions on breast cancer concerns.

ACD/Labs collaborate with leading Alzheimer’s research scientist to evaluate CNS drugs, and offer a deeper understanding of the parameters that effect blood brain barrier permeability.